close icon

DexCom ‘s Wall Street Darling Status is in Danger

In previous articles, we’ve discussed numerous stocks, which brought their investors great returns in the past decade. Today’s material will focus on one that beats them all. DexCom – a medical device company, headquartered in San Diego, California.

In November 2008, during the throes of the Financial Crisis, DXCM stock plunged to as low as $1.36 a share. In August 2019, the price reached an all-time high of $178.45. The math says this is 55.8% compounded annually for a total return of 13 000% in less than eleven years.

In contrast, the low at $1.36 in 2008 was the result of a selloff from $26.70 in April 2006. It turns out DexCom stock is not immune to price declines after all. The danger is that after many years of huge gains investors tend to forget the fact that no trend lasts forever. So let’s examine DexCom’s bull market through the prism of the Elliott Wave principle and see what’s left of it.

Complete Elliott Wave impulse can lead to a 70% crash in DexCom stock

DexCom’s weekly logarithmic chart reveals that a complete five-wave impulse pattern has been formed. What the bulls probably don’t want to hear is that according to the Elliott Wave theory, every impulse is followed by a three-wave correction in the other direction.

This is the same pattern which led to an 86% crash in Cigna in 2007-2008. A complete impulse pattern was also visible on the chart of EQT Corp. right before its own 85% dive. In other words, a fully-formed impulse, labeled I-II-III-IV-V, must not be taken lightly by DexCom shareholders.

Usually, the corrective phase of the wave cycle erases all of the fifth wave’s gains. In DXCM’s case, this means a pullback to at least $42 a share where the support of wave IV lies. This would be a massive 70% crash from the current level of $147. Given that the company is barely profitable, we wouldn’t be surprised to see an even larger selloff in DexCom.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!

Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Dell Stock Trading in Fifth and Final Wave

Investors who were brave or fortunate enough to buy Dell Technologies during the coronavirus panic of March 2020 must be very pleased with the results. The stock is up 338% from that bottom at $25.51 and closed at $111.63 yesterday. For a profitable, growing and financially sound company like Dell, that surge is not a…

Read More »

Has ServiceNow ‘s Bubble Finally Reached its Limit?

After the huge success of Amazon Web Services, it is easy to see why cloud computing is such a hot sector right now. However, no trend lasts forever and no stock remains a Wall Street darling indefinitely. Today, we’d like to examine another red-hot company in the cloud industry – ServiceNow Inc. With a market…

Read More »

Megacable Stock – A Pattern 13 Years in the Making

Megacable Holdings engages in the provision of telecom services to 250 cities in 25 states in Mexico. Headquartered in Guadalajara, the company was founded in 1982 but did not go public before late-2007. Listing on a public market in 2007 practically guaranteed terrible stock performance over the next year or so during the global Financial…

Read More »

GN Store Nord Stock On Its Way to the Bargain Bin

In case you didn’t know, GN Store Nord A/S is a leading hearing aid devices manufacturer, based in Denmark. The company’s annual sales are expected to exceed DKK 15 billion this year. According to Statista, GN held a 15% share of the global hearing aid device market in 2019. Considering that its growth rate has…

Read More »

Roku Down 37% as Elliott Wave Correction Unfolds

We last wrote about Roku in the spring, on May 24th, 2021. The stock was hovering around $330 a share. Fundamentally speaking, we thought that even this was too high a price. A quick look on the company’s weekly chart, however, convinced us that “Roku ‘s bubble can keep inflating”. Not indefinitely, though. The anticipated…

Read More »

Three Months Ahead of NovoCure ‘s 35% Plunge

Our first and only article on NovoCure stock was published almost three months ago, on July 1st. In it we shared our view that the tumor treatment company was not only significantly overvalued, but in immediate danger of a large stock price drop. The stock had just fell 15% in one day, despite positive TTFields…

Read More »

MongoDB – Bearish Pattern Joins Nosebleed Valuation

MongoDB Inc. is a general purpose database platform developer and provider. The company was founded in 2007, but only came public ten years later – in 2017. During the following four years, the stock has risen from an IPO price of $33 to $515 a share as of last week. So, it is fair to…

Read More »

More analyses